Biblio Discovery — Demo Discovery Service

19 results for "Scott Read"

Showing 1–19 · 0.46 seconds · RSS

  1. Journal Article Full text

    Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension

    Eric Kalo; Scott Read; Golo Ahlenstiel

    Livers, Vol. 1 No. 3 · 2021 · English · DOAJ Scopus

    Antifibrotic therapies for the treatment of liver fibrosis represent an unconquered area of drug development. The significant involvement of the gut microbiota as a driving force in a multitude of liver disease, be it pathogenesis or fibrotic progression, suggest that targeting the gut–liver axis…

  2. Journal Article Full text

    Reprogramming—Evolving Path to Functional Surrogate β-Cells

    Eric Kalo; Scott Read; Golo Ahlenstiel

    Cells, Vol. 11 No. 18 · 2022 · English · DOAJ Scopus

    Numerous cell sources are being explored to replenish functional β-cell mass since the proof-of -concept for cell therapy of diabetes was laid down by transplantation of islets. Many of these cell sources have been shown to possess a degree of plasticity permitting differentiation along new…

  3. Journal Article

    The unwell patient with advanced chronic liver disease: when to use each score?

    Oliver Moore; Wai-See Ma; Scott Read et al.

    BMC Medicine, Vol. 23 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Prognostication in chronic liver disease and the implementation of appropriate scoring systems is difficult given the variety of clinical manifestations. It is important to understand the limitations of each scoring system as well as the context and patient group from which it…

  4. Journal Article Full text

    A Call for Implementation of an Evidence-Based, Quality Improvement, Decompensated Cirrhosis Discharge Care Bundle in Australia

    Eric Kalo; Nashwa Sheriff; Marina Isaac et al.

    Livers, Vol. 2 No. 2 · 2022 · English · DOAJ Scopus

    A growing body of research suggests that evidence-based interventions can tackle high rates of hospital readmissions among patients with decompensated cirrhosis. Care bundles are a prime example of an evidence-based intervention to reduce hospital readmissions through documentation and…

  5. Journal Article

    Attitudes towards transjugular intrahepatic portosystemic shunt (TIPS) in Australia: a national survey of TIPS centres

    Jacob George; Avik Majumdar; Golo Ahlenstiel et al.

    BMJ Open Gastroenterology, Vol. 11 No. 1 · 2024 · English · DOAJ Scopus

    Background Transjugular intrahepatic portosystemic shunt (TIPS) is a minimally invasive therapeutic option to treat the sequelae of portal hypertension. It is unclear whether current international recommendations are reflected in current clinical practice across Australia and the extent of…

  6. Journal Article Full text

    Validation and Comparison of Non-Invasive Tests for the Exclusion of High-Risk Varices in Compensated Advanced Chronic Liver Disease

    Rajiv Kurup; Eric Kalo; Scott Read et al.

    Livers, Vol. 4 No. 2 · 2024 · English · DOAJ Scopus

    Non-invasive tests (NITs) are a potential alternative to screening oesophagogastroduodenoscopy (OGD) for ruling out high-risk varices (HRVs) in patients with compensated advanced chronic liver disease (cACLD). This retrospective study aimed to externally validate and compare various NITs in a…

  7. Journal Article

    Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review

    Meryem Jefferies; Robert Graham; Marguerite Tracy et al.

    Journal of Medical Internet Research, Vol. 26 · 2024 · English · DOAJ Scopus

    BackgroundThe COVID-19 pandemic impacted patients with substance use disorder (SUD) more than the general population and resulted in substantially increased emergency department admissions. Routine care of patients attending drug health services during the pandemic transitioned, with telehealth…

  8. Journal Article

    A novel, nurse-led ‘one stop’ clinic for patients with liver cirrhosis results in fewer liver-related unplanned readmissions and improved survival

    Eric Kalo; Asma Baig; Emily Gregg et al.

    BMC Gastroenterology, Vol. 23 No. 1 · 2023 · English · DOAJ Scopus

    Abstract Objective Delivering effective secondary preventive and integrated care has the potential to break the revolving-door phenomenon of frequent readmissions in patients with advanced chronic liver disease. To address this, we launched the Care Coordination of Liver Disease (CCoLD) pilot, a…

  9. Journal Article

    Prognostic Role of Acute-on-Chronic Liver Failure in Acute Variceal Bleeding: A Multicenter Retrospective Study in Australia

    Rajiv Kurup; Huu Hoang Hiep Dao; Pei-Yu Lin et al.

    Gut and Liver, Vol. 20 No. 5 · 2026 · English · DOAJ Scopus

    Background/Aims : Acute variceal bleeding (AVB) is a life-threatening complication of cirrhosis that can precipitate acute-on-chronic liver failure (ACLF), leading to poor outcomes. This multicenter retrospective study evaluated the impact of ACLF on the long-term outcomes of patients admitted with…

  10. Journal Article

    Using a human colonoid-derived monolayer to study bacteriophage translocation

    Huu Thanh Le; Alicia Fajardo Lubian; Bethany Bowring et al.

    Gut Microbes, Vol. 16 No. 1 · 2024 · English · DOAJ Scopus

    ABSTRACTBacteriophages (phages) are estimated to be the most abundant microorganisms on Earth. Their presence in human blood suggests that they can translocate from non-sterile sites such as the gastrointestinal tract where they are concentrated. To examine phage translocation ex vivo, we adapted a…

  11. Journal Article

    Non-risk-based HCV screening at point of care: a prospective pilot

    Jeenat Paulose; Nishita Jagarlamudi; Dmitrii Shek et al.

    BMC Infectious Diseases, Vol. 26 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Hepatitis C virus (HCV) transmission continues to be a significant problem among high-risk populations and has prompted widespread risk-factor based screening in Australia. Current evidence indicates a higher-than-expected local HCV prevalence in non-high-risk populations…

  12. Journal Article

    Dynamic Changes in Bilirubin Predict 90-Day Mortality in Patients With Hepatocellular Carcinoma and Acute Decompensations of Cirrhosis: The HCC-AD Score

    Oliver Moore, MBBS; Fran Neveu-Coble, BN; Scott Read, PhD et al.

    Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol. 9 No. 5 · 2025 · English · DOAJ Scopus

    Objective: To develop a score to predict 90-day mortality in patients with hepatocellular carcinoma (HCC) admitted with an acute decompensation (AD) event of chronic liver disease. Patients and Methods: This retrospective cohort study was conducted at Blacktown and Westmead Hospitals in Australia…

  13. Journal Article Full text

    Associations Between Uraemic Toxins and Gut Microbiota in Adults Initiating Peritoneal Dialysis

    Philippa James; Jordan Stanford; Ojas V. A. Dixit et al.

    Toxins, Vol. 17 No. 7 · 2025 · English · DOAJ Scopus

    Declining kidney function contributes to the accumulation of uraemic toxins produced by gut microbiota, leading to the uraemic syndrome. This study aimed to identify associations between uraemic toxins, diet quality, symptoms and the gut microbiota in individuals initiating peritoneal dialysis. A…

  14. Journal Article Full text

    COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out

    Meryem Jefferies; Harunor Rashid; Robert Graham et al.

    Vaccines, Vol. 10 No. 6 · 2022 · English · DOAJ Scopus

    Background: In this study, we determined the impact of the COVID-19 pandemic on Western Sydney patients with substance use disorders (SUD) by comparing emergency department (ED) admission rates before and after the onset of the COVID-19 pandemic and before the rollout of COVID-19 vaccination…

  15. Journal Article

    Efficacy of albumin use in decompensated cirrhosis and real‐world adoption in Australia

    Eric Kalo; Scott Read; Asma Baig et al.

    JGH Open, Vol. 8 No. 9 · 2024 · English · DOAJ Scopus

    Abstract The current treatment approach to patients with liver cirrhosis relies on the individual management of complications. Consequently, there is an unmet need for an overall therapeutic strategy for primary and secondary prevention of complications. The clinical potential of long‐term albumin…